Increasing evidence has associated elevated RhoA signaling with human cancer metastasis and progression [24,25], through increased RhoA expression [26,27,28], activating mutation or increased expression of GEFs [29,30,31], or from deletion or decreased expression of GAPs [32,33]. The gene discussed is RHOA; the disease is cancer.